Recent Finacing
Recent Raise
InventisBio is a Shanghai-based clinical-stage biotech discovering and developing proprietary small-molecule therapeutics—SERD for HR+ breast cancer, third-generation EGFR TKI for EGFR‑mutant NSCLC, and a gout candidate.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at InventisBio.
